Potential of zebrafish for anticancer drug screening

Expert Opinion on Drug Discovery

Volumn 3, Issue 12, 2008, Pages 1451-1460

  Le, Xiuning ^a   Zon, Leonard I ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer model; Chemical screen; Zebrafish

Indexed keywords

ANTINEOPLASTIC AGENT; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL EMBRYO; CANCER MODEL; CHEMICAL CARCINOGENESIS; DRUG SCREENING; GENETIC ENGINEERING; GENETIC MODEL; HEMATOPOIETIC STEM CELL; HIGH THROUGHPUT SCREENING; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSGENICS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ZEBRA FISH;

EID: 58049216580     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440802580171     Document Type: Review

References (71)

1. The Beginnings: Laboratory and Animal Studies. 2008 [cited;Available from: http://www.fda.gov/fdac/special/testtubetopatient/studies.html
2. Cancer Trend Progress Report - 2007 Update. 2007 [cited]. Available from: http://progressreport.cancer.gov/
3. Amatruda JF, Shepard JL, Stern HM, et al. Zebrafish as a cancer model system. Cancer Cell 2002;1(3):229-31
4. Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008;27(33):4509-20
5. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005;4(1):35-44
6. Stern HM, Zon LI. Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer 2003;3(7):533-9
7. Zebrafish. 2008 [cited] Available from: http://en.wikipedia.org/wiki/ Danio_rerio
8. Haffter P, Granato M, Brand M, et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996;123:1-36
9. Driever W, Solnica-Krezel L, Schier AF, et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996;123:37-46
10. Amsterdam A, Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet 2006;22(9):473-8
11. Spitsbergen JM, Tsai HW, Reddy A, et al. Neoplasia in zebrafish (Danio rerio) treated with N-metbyI-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 2000;28(5):716-25
12. Beckwith LG, Moore JL, Tsao-Wu GS, et al. Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Lab Invest 2000;80(3):379-85
13. Mizgireuv IV, Majorova IG, Gorodinskaya VM, et al. Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio). Toxicol Pathol 2004;32(5):514-8
14. Haldi M, Ton C, Seng WL, et al. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 2006;9(3):139-51
15. Lee LM, Seftor EA, Bonde G, et al. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 2005;233(4):1560-70
16. Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2007;2(11):2918-23
17. Nicoli S, Ribatti D, Cotelli F, et al. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007;67(7):2927-31
18. Langenau DM, Traver D, Ferrando AA, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003;299(5608):887-90
19. Onnebo SM, Condron MM, McPhee DO, et al. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol 2005;33(2):182-8
20. Patton EE, Widlund HR, Kutok JL, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005;15(3):249-54
21. MacInnes AW, Amsterdam A, Whittaker CA, et al. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci USA 2008;105(30):10408-13
22. Langenau DM, Jette C, Berghmans S, et al. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 2005;105(8):3278-85
23. Yang HW, Kutok JL, Lee NH, et al. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res 2004;64(20):7256-62
24. Sabaawy HE, Azuma M, Embree LJ, et al. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006;103(41):15166-71
25. Langenau DM, Keefe MD, Storer NY, et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 2007;21(11):1382-95
26. Le X, Langenau DM, Keefe MD, et al. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci USA 2007;104(22):9410-5
27. Chen J, Jetre C, Kanki JP, et al. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 2007;21(3):462-71
28. Park SW, Davison JM, Rhee J, et al. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 2008;134(7):2080-90
29. Berghmans S, Murphey RD, Wienholds E, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acid Sci USA 2005;102(2):407-12
30. Haramis AP, Hurlstone A, van der Velden Y, et al. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006;7(4):444-9
31. Faucherre A, Taylor GS, Overvoorde J, et al. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 2008;27(8):1079-86
32. Zhuravleva J, Solary E, Chluba J, et al. A role for the transcription intermediary factor 2 in zebrafish myelopoiesis. Exp Hematol 2008;36(5):559-67
33. Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004;2(5):E139
34. Lam SH, Wu YL, Vega VB, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 2006;24(1):73-5
35. Goessling W, North TE, Zon LI. New waves of discovery: modeling cancer in zebrafish. J Clin Oncol 2007;25(17):2473-9
36. Lam SH, Gong Z. Modeling liver cancer using zebrafish: a comparative oncogenomics approach. Cell Cycle 2006;5(6):573-7
37. Stoletov K, Montel V, Lester RD, et al. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007;104(44):17406-11
38. Langenau DM, Feng H, Berghmans S, et al. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2005;102(17):6068-73
39. Feng H, Langenau DM, Madge JA, et al. Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/Iox-regulated transgenic zebrafish. Br J Haematol 2007;138(2):169-75
40. Huang CJ, Jou TS, Ho YL, et al. Conditional expression of a myocardium-specific transgene in zebrafish transgenic lines. Dev Dyn 2005;233(4):1294-303
41. Stemple DL. TILLING-a high-throughput harvest for functional genomics. Nat Rev Genet 2004;5(2):145-50
42. Parng C, Seng WL, Semino C, et al. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002;1(l Pt 1):41-8
43. Sharpless NE, Depinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006;5(9):741-54
44. Peterson RT, Link BA, Dowling JE, et al. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 2000;97(24):12965-9
45. Peterson RT, Shaw SY, Peterson TA, et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22(5):595-9
46. Stern HM, Murphey RD, Shepard JL, et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 2005;1(7):366-70
47. North TE, Goessling W, Walkley CR, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007;447(7147):1007-11
48. Silva MT, do Vale A, dos Santos NM. Fish and apoptosis: studies in disease and pharmaceutical design. Curr Pharm Des 2008;14(2):170-83
49. Pyati UJ, Look AT, Hammerschmidt M. Zebrafish as a powerful vertebrate model system for in vivo studies of cell death. Semin Cancer Biol 2007;17(2):154-65
50. Sidi S, Sanda T, Kennedy RD, et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008;133(5):864-77
51. Murphey RD, Stern HM, Straub CT, Zon LI. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 2006;68(4):213-9
52. Dorsky RI, Sheldahl LC, Moon RT. A transgenic Lef1/ beta-catenin-dependent reporter is expressed in spatially restricted domains throughout zebrafish development. Dev Biol 2002;241(2):229-37
53. Varga M, Maegawa S, Bellipanni G, et al. Chordin expression, mediated by Nodal and FGF signaling, is restricted by redundant function of two beta-catenins in the zebrafish embryo. Mech Dev 2007;124(9-10):775-91
54. Langenau DM, Ferrando AA, Traver D, et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci USA 2004;101(19):7369-74
55. Langenau DM, Zon LI. The zebrafish: a new model of T-cell and thymic development. Nat Rev Immunol 2005;5(4):307-17
56. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th edition. Univ of Oregon Press, Eugene; 2000
57. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452(7187):580-9
58. Goessling W, North TE, Zon LI. Ultrasound biomicroscopy permits in vivo characterization of zebrafish liver tumors. Nat Methods 2007;4(7):551-3
59. Detrich HW 3rd. Fluorescent proteins in zebrafish cell and developmental biology. Methods Cell Biol 2008;85:219-41
60. Rohde CB, Zeng F, Gonzalez-Rubio R, et al. Microfluidic system for on-chip high-throughput whole-animal sorting and screening at subcellular resolution. Proc Natl Acad Sci USA 2007;104(35):13891-5
61. Tran TC, Sneed B, Haider J, et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res 2007;67(23):11386-92
62. Rizzi B, Campana M, Zanella C, et al. 3-D zebrafish embryo image filtering by nonlinear partial differential equations. Conf Proc IEEE Eng Med Biol Soc 2007;2007:6252-5
63. Her GM, Yeh YH, Wu JL. 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish. Dev Dyn 2003;227(3):347-56
64. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002;248(2):307-18
65. White RM, Sessa A, Burke C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008;2(2):183-9
66. Mizgireuv IV, Revskoy SY. Transplantable tumor lines generated in clonal zebrafish. Cancer Res 2006;66(6):3120-5
67. Haigis KM, Kendall KR, Wang Y, et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 2008;40(5):600-8
68. Zhang Y, Yeh JR, Mara A, et al. A chemical and genetic approach to the mode of action of fumagillin. Chem Biol 2006;13(9):1001-9
69. Peterson RT. A noncanonical path to mechanism of action. Chem Biol 2006;13(9):924-6
70. Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 2000;26(2):216-20
71. Stemple DL, Driever W. Zebrafish tools for investigating cellular differentiation. Curr Opin Cell Biol 1996;8(6):858-64.